With several products currently in the clinic and a compelling long-term vision for our future, Facet Biotech is a small but sophisticated biotechnology company. Combining our expertise in antibody engineering with a disciplined, biology-driven research approach, our company is dedicated to advancing our current pipeline of four clinical-stage products and leveraging our research and development capabilities to identify and develop new drugs. We are passionate and committed about the work that we do, and we share a common goal of developing therapeutics that will improve people’s lives.

Facet Biotech Corporation launched in December 2008 as a spin-off from PDL BioPharma, Inc.

Biotechnology

Facet Biotech

Facet Biotech's headquarters in United States

Description

People (7)

Suresh Khemani

Merlyn Recio

Pamela McCall

Steve Keller

Fang Yuni

Linda Pete

Pui Seto

Jobs